01.10.2026

Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”

Swissmedic has updated the Guidance document on parallel imports. In particular, the changes concern clarifications on country of export, additions to the requirements for packaging, storage instructions and information on handling in the medicinal product information for parallel imported medicinal products

01.10.2026

Revision of the Guidance document Authorisation Biosimilar

Following finalisation of the EMA Reflection paper on a tailored clinical approach in biosimilar development, the Guidance document Authorisation Biosimilar has been adapted accordingly

01.10.2026

Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances

As of 15 November 2026, the prior registration of active substances in the EMA SMS database (Substances Management Services) will become a mandatory requirement for their inclusion in establishment licences and GMP certificates

29.09.2026

HPC - Librela ad us. vet., Injektionslösung für Hunde (Bedinvetmabum)

Neue Vorsichtsmassnahmen für die Anwendung bei Tieren und neue Nebenwirkungen

26.09.2026

DHPC – Clozapin

Überarbeitete Empfehlungen für die routinemässige Kontrolle des Blutbildes im Hinblick auf das Risiko einer Agranulozytose

25.09.2026

DHPC – Remsima® (Infliximab)

Die neue intravenöse Formulierung (100 mg und 350 mg, Konzentrat zur Herstellung einer Infusionslösung) enthält Sorbitol und ist daher bei Patientinnen und Patienten mit hereditärer Fruktoseintoleranz (HFI) kontraindiziert

25.09.2026

Out-of-Stock – Ketazed, Augentropfen-Lösung

Befristete Bewilligung zum Vertrieb in schwedischer / finnischer Aufmachung

24.09.2026

Swissmedic Portal Release – New Features Available from 23 September 2026

Submission of major changes (establishment licences) and viewing of specialist data for complementary medicines in the notification procedure

In focus

Fillerbehandlungen

Filler Treatments

The video highlights the risks of not getting filler treatment from a specialist and explains how to reduce these risks. 

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to questions@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Summary report on authorisation

Featured


Swissmedic video portrait

Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.

What is a medicinal product?

Did you know that tea can also be a medicinal product? But what exactly constitutes a medicinal product and how does it differ from other products? You will find answers to these and other questions in this video.

Delimitation questions in human health

In order for a product to be sold, it must comply with the relevant legal regulations. However, it’s not often immediately apparent which product group it belongs to. In this video, we explain what different categories there are, and when a product is really a therapeutic product – and when it is not!

Symbolbild_IVD

01.07.2026

Introduction of the obligation to register in swissdamed

The obligation to register products for medical devices, in vitro diagnostic medical devices, as well as systems and procedure packs in swissdamed has applied since 1 July 2026 (communication.
The factsheet “Economic operators” (PDF, 1 MB, 01.05.2026) and the “swissdamed” section of the website have been updated.
Further information on the EU Regulations and their implementation in Switzerland is available under: Legal framework.

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html